FDA Reclassifies 12 Peptides: What April 2026's Policy Shift Means for Biohackers
FDA Reclassifies 12 Peptides: What April 2026's Policy Shift Means for Biohackers The FDA's April 15, 2026 reclassification of 12 research peptides marks the most significant regulatory shift in the space since the 2023 compounding crackdown. Here's a breakdown of the affected compounds, the new compliance landscape…
The FDA's April 15, 2026 reclassification of 12 research peptides marks the most significant regulatory shift in the space since the 2023 compounding crackdown. Here's a breakdown of the affected compounds, the new compliance landscape, and how to think about your protocol going forward.
Peptide South Africa Research Research TeamEditorial
#MOTS-C#Compounding#FDA#2026 Policy#Peptide Regulation#BPC-157#Peptide Compliance#biohackingShare this articleTwitterLinkedInTrack Your Peptide Protocols
Use Peptide South Africa Research to log injections, calculate doses, access our peptide library, and optimize your protocols.
Download Peptide South Africa ResearchExplore More Peptide ResourcesFree peptide calculators·Peptide research hub·Peptide glossary·Semaglutide guide·BPC-157 guide·Best peptide calculator